business
What Does an Adaptive Biotech Insider's Sale of Nearly 40,000 Shares Mean for Investors?
Key takeaways
- ADPT Francis Lo, Chief People Officer of Adaptive Biotechnologies (NASDAQ:ADPT), reported the sale of 39,741 shares of Common Stock for a transaction value of approximately $695,000, as disclosed in a SEC Form 4 filing.
- Post-transaction value (direct ownership)
- Transaction and post-transaction values based on SEC Form 4 weighted average reported price ($17.49).
ADPT Francis Lo, Chief People Officer of Adaptive Biotechnologies (NASDAQ:ADPT), reported the sale of 39,741 shares of Common Stock for a transaction value of approximately $695,000, as disclosed in a SEC Form 4 filing.
Post-transaction value (direct ownership)
Transaction and post-transaction values based on SEC Form 4 weighted average reported price ($17.49).
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
BBC News
What does 1-0 win mean for Scotland's chances of qualification?
Investing.com
Explainer-A key surveillance law is expiring. What does that mean for U.S. intelligence?
Investing.com
Sigma Healthcare withdraws from Boots sale process; shares jump
ARY News
Japanese investors sought more than $6.2 billion worth of SpaceX shares at IPO, sources say
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop